» Download Public Reports
About 500 reports
- Company report
- February 2013
- 5 pages
- by Intergovernmental Agency
February 2013
... The commercialisation of valirx S portfolio of innovative technologies Valirx plc (aim: val), a life science company in clinical development with anti-cancer diagnostics and therapeutics for personalised medicine ...
March 2013
... That marks a milestone in cancer therapy. About roche headquartered in basel, switzerland, roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics ...
April 2013
... Geographic expansion into scotland, providing the opportunity to establish an overnight service for dna sequencing accessible by the scottish research community The current inverclyde biologicals directors ...
February 2013
... Pharmaceutical company with a companion diagnostic client Leading european global pharmaceutical company need The company needed to understand the reimbursement environment for high price / high value ...
April 2013
... Clinics-ambulatory-care-centers-surgery-cente-market-report.Html sales and market share analysis - sales and market shares of major coagulation reagent and instrument suppliers. Current and emerging products - analysis of coagulation procedures performed in poc ...
April 2013
... According to the program "the development of healthcare in russia" from 2014 to 2018.. Spect spect/ct pet/ct spect spect/ct pet/ct 8 in the nuclear medicine field we perform the following functions 1 ...
» Purchase Premium Reports
(From $ 250 - $ 12 800)
About 2 100 reports
- $ 12 800
- Industry report
- February 2013
- by Venture Planning Group
This new 450-page five-country study from Venture Planning Group presents test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of ...
February 2013
$ 12 800
This new 1,600-page five-country report from Venture Planning Group is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ...
February 2013
$ 12 800
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...
February 2013
$ 12 800
This new 600-page five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood ...
February 2013
$ 12 800
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...
February 2013
$ 12 800
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging ...
February 2013
$ 12 800
This new 500-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...